Display options
Cite
Pei XD, He ZL, Yao HL, et al. 6-Shogaol from ginger shows anti-tumor effect in cervical carcinoma via PI3K/Akt/mTOR pathway. Eur J Nutr. 2021;60(5):2781-2793doi: 10.1007/s00394-020-02440-9.
Pei, X. D., He, Z. L., Yao, H. L., Xiao, J. S., Li, L., Gu, J. Z., Shi, P. Z., Wang, J. H., & Jiang, L. H. (2021). 6-Shogaol from ginger shows anti-tumor effect in cervical carcinoma via PI3K/Akt/mTOR pathway. European journal of nutrition, 60(5), 2781-2793. https://doi.org/10.1007/s00394-020-02440-9
Pei, Xiao-Dong, et al. "6-Shogaol from ginger shows anti-tumor effect in cervical carcinoma via PI3K/Akt/mTOR pathway." European journal of nutrition vol. 60,5 (2021): 2781-2793. doi: https://doi.org/10.1007/s00394-020-02440-9
Pei XD, He ZL, Yao HL, Xiao JS, Li L, Gu JZ, Shi PZ, Wang JH, Jiang LH. 6-Shogaol from ginger shows anti-tumor effect in cervical carcinoma via PI3K/Akt/mTOR pathway. Eur J Nutr. 2021 Aug;60(5):2781-2793. doi: 10.1007/s00394-020-02440-9. Epub 2021 Jan 08. PMID: 33416981.
Copy Download .nbib Format: NLM
Share it on

Eur J Nutr. 2021 Aug;60(5):2781-2793. doi: 10.1007/s00394-020-02440-9. Epub 2021 Jan 08.

6-Shogaol from ginger shows anti-tumor effect in cervical carcinoma via PI3K/Akt/mTOR pathway.

European journal of nutrition

Xiao-Dong Pei, Zhi-Long He, Hong-Liang Yao, Jun-Song Xiao, Lan Li, Jian-Zhong Gu, Pei-Zhao Shi, Jin-Hua Wang, Li-He Jiang

Affiliations

  1. College of Light Industry and Food Engineering, Guangxi University, Nanning, 530004, Guangxi, People's Republic of China.
  2. State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, People's Republic of China.
  3. Guangdong Key Laboratory of Animal Conservation and Resource Utilization, Guangdong Public Laboratory of Wild Animal Conservation and Utilization, Institute of Zoology, Guangdong Academy of Sciences, Guangdong, 510260, People's Republic of China.
  4. Beijing Higher Institution Engineering Research Center of Food Additives and Ingredients, Beijing Technology and Business University-BTBU, Beijing, 100048, People's Republic of China.
  5. School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, 533000, Guangxi, People's Republic of China.
  6. West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, 610041, Sichuan, People's Republic of China.
  7. College of Light Industry and Food Engineering, Guangxi University, Nanning, 530004, Guangxi, People's Republic of China. [email protected].
  8. State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, People's Republic of China. [email protected].
  9. School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, 533000, Guangxi, People's Republic of China. [email protected].
  10. Medical College, Guangxi University, Nanning, 530004, Guangxi, People's Republic of China. [email protected].

PMID: 33416981 DOI: 10.1007/s00394-020-02440-9

Abstract

PURPOSE: 6-Shogaol, an active phenolic compound from ginger (Zingiber officinale), can inhibit the growth of a variety of human cancer cells. Nevertheless, its underlying molecular mechanisms in cervical cancer remain unclear. In this study, we systematically examine the inhibitory effect of 6-shogaol on cervical cancer in vitro and in vivo.

METHODS: Cell proliferation was assessed by CCK8 assay and colony formation assay in HeLa and SiHa cells. We analyzed cell cycle and apoptosis through flow cytometry. GFP-LC3 puncta and transmission electron microscopy were used to observe autophagic bodies. Wound-healing assay and transwell assay were used for evaluating the migration of cells. Western blot was applied to detect protein expression levels.

RESULTS: 6-Shogaol could suppress cell proliferation and migration, cause cell cycle arrest in the G2/M phase in HeLa and SiHa cells. Moreover, 6-shogaol triggered the apoptosis process through the mitochondrial pathway by downregulating the expression levels of p-PI3K, p-Akt and p-mTOR. Further research indicated that the induction of apoptosis by 6-shogaol was remarkably decreased after the treatment of ROS scavenger and PI3K agonist. Additionally, 6-shogaol increased the number of LC3-positive puncta and autophagic bodies per cell in both HeLa and SiHa cells. Pretreatment of cells with Bafilomycin A1, an autophagy inhibitor, accelerated 6-shogaol mediated cell apoptosis, suggesting that induction of autophagy by 6-shogaol is suppressive to apoptosis. Furthermore, in vivo data revealed that 6-shogaol significantly inhibited tumor growth and cell proliferation in tumor tissues.

CONCLUSION: These findings suggested that 6-shogaol could be developed as a functional food ingredient, which is potentially used as therapeutic agents for patients with cervical cancer.

© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.

Keywords: 6-Shogaol; Apoptosis; Autophagy; Cell migration; PI3K/Akt/mTOR pathway

References

  1. Chrysostomou AC, Stylianou DC, Constantinidou A, Kostrikis LG (2018) Cervical cancer screening programs in Europe: the transition towards HPV vaccination and population-based HPV testing. Viruses. https://doi.org/10.3390/v10120729 - PubMed
  2. Li H, Wu X, Cheng X (2016) Advances in diagnosis and treatment of metastatic cervical cancer. J Gynecol Oncol 27(4):e43. https://doi.org/10.3802/jgo.2016.27.e43 - PubMed
  3. Mrklas KJ, MacDonald S, Shea-Budgell MA, Bedingfield N, Ganshorn H, Glaze S, Bill L, Healy B, Healy C, Guichon J, Colquhoun A, Bell C, Richardson R, Henderson R, Kellner J, Barnabe C, Bednarczyk RA, Letendre A, Nelson GS (2018) Barriers, supports, and effective interventions for uptake of human papillomavirus- and other vaccines within global and Canadian Indigenous peoples: a systematic review protocol. Syst Rev 7(1):40. https://doi.org/10.1186/s13643-018-0692-y - PubMed
  4. Ali BH, Blunden G, Tanira MO, Nemmar A (2008) Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol 46(2):409–420. https://doi.org/10.1016/j.fct.2007.09.085 - PubMed
  5. Lantz RC, Chen GJ, Sarihan M, Solyom AM, Jolad SD, Timmermann BN (2007) The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine 14(2–3):123–128. https://doi.org/10.1016/j.phymed.2006.03.003 - PubMed
  6. Shukla Y, Singh M (2007) Cancer preventive properties of ginger: a brief review. Food Chem Toxicol 45(5):683–690. https://doi.org/10.1016/j.fct.2006.11.002 - PubMed
  7. Ling H, Yang H, Tan SH, Chui WK, Chew EH (2010) 6-Shogaol, an active constituent of ginger, inhibits breast cancer cell invasion by reducing matrix metalloproteinase-9 expression via blockade of nuclear factor-kappaB activation. Br J Pharmacol 161(8):1763–1777. https://doi.org/10.1111/j.1476-5381.2010.00991.x - PubMed
  8. Jolad SD, Lantz RC, Solyom AM, Chen GJ, Bates RB, Timmermann BN (2004) Fresh organically grown ginger (Zingiber officinale): composition and effects on LPS-induced PGE2 production. Phytochemistry 65(13):1937–1954. https://doi.org/10.1016/j.phytochem.2004.06.008 - PubMed
  9. Jolad SD, Lantz RC, Chen GJ, Bates RB, Timmermann BN (2005) Commercially processed dry ginger (Zingiber officinale): composition and effects on LPS-stimulated PGE2 production. Phytochemistry 66(13):1614–1635. https://doi.org/10.1016/j.phytochem.2005.05.007 - PubMed
  10. Hung JY, Hsu YL, Li CT, Ko YC, Ni WC, Huang MS, Kuo PL (2009) 6-Shogaol, an active constituent of dietary ginger, induces autophagy by inhibiting the AKT/mTOR pathway in human non-small cell lung cancer A549 cells. J Agric Food Chem 57(20):9809–9816. https://doi.org/10.1021/jf902315e - PubMed
  11. Tan BS, Kang O, Mai CW, Tiong KH, Khoo AS, Pichika MR, Bradshaw TD, Leong CO (2013) 6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor gamma (PPARgamma). Cancer Lett 336(1):127–139. https://doi.org/10.1016/j.canlet.2013.04.014 - PubMed
  12. Liang T, He Y, Chang YH, Liu XT (2019) 6-shogaol a active component from ginger inhibits cell proliferation and induces apoptosis through inhibition of STAT-3 translocation in ovarian cancer cell lines (A2780). Biotechnol Bioproc E 24(3):560–567. https://doi.org/10.1007/s12257-018-0502-3 - PubMed
  13. Li TY, Chiang BH (2017) 6-shogaol induces autophagic cell death then triggered apoptosis in colorectal adenocarcinoma HT-29 cells. Biomed Pharmacother 93:208–217. https://doi.org/10.1016/j.biopha.2017.06.038 - PubMed
  14. Kondo Y, Kanzawa T, Sawaya R, Kondo S (2005) The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5(9):726–734. https://doi.org/10.1038/nrc1692 - PubMed
  15. Levine B, Klionsky DJ (2004) Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6(4):463–477. https://doi.org/10.1016/s1534-5807(04)00099-1 - PubMed
  16. Codogno P, Mehrpour M, Proikas-Cezanne T (2011) Canonical and non-canonical autophagy: variations on a common theme of self-eating? Nat Rev Mol Cell Biol 13(1):7–12. https://doi.org/10.1038/nrm3249 - PubMed
  17. Carew JS, Nawrocki ST, Kahue CN, Zhang H, Yang C, Chung L, Houghton JA, Huang P, Giles FJ, Cleveland JL (2007) Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood 110(1):313–322. https://doi.org/10.1182/blood-2006-10-050260 - PubMed
  18. Man S, Wang H, Zhou J, Lu Y, Su Y, Ma L (2019) Cardiac glycoside compound isolated from Helleborus thibetanus Franch displays potent toxicity against HeLa cervical carcinoma cells through ROS-independent autophagy. Chem Res Toxicol 32(12):2479–2487. https://doi.org/10.1021/acs.chemrestox.9b00318 - PubMed
  19. Wang Q, Yan SP, Chu DX, Xie Y, Wang CF, Zhang JY, Li WC, Guo RX (2019) Silencing of Long Non-Coding RNA RP1-93H18.6 acts as a tumor suppressor in cervical cancer through the blockade of the PI3K/Akt axis. Mol Ther Nucleic Acids 19:304–317. https://doi.org/10.1016/j.omtn.2019.10.041 - PubMed
  20. Weidner MS, Sigwart K (2000) The safety of a ginger extract in the rat. J Ethnopharmacol 73(3):513–520. https://doi.org/10.1016/s0378-8741(00)00340-8 - PubMed
  21. Mahomoodally MF, Aumeeruddy MZ, Rengasamy KRR, Roshan S, Hammad S, Pandohee J, Hu X, Zengin G (2019) Ginger and its active compounds in cancer therapy: from folk uses to nano-therapeutic applications. Semin Cancer Biol. https://doi.org/10.1016/j.semcancer.2019.08.009 - PubMed
  22. Schwartz GK, Shah MA (2005) Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol 23(36):9408–9421. https://doi.org/10.1200/JCO.2005.01.5594 - PubMed
  23. Wu JJ, Omar HA, Lee YR, Teng YN, Chen PS, Chen YC, Huang HS, Lee KH, Hung JH (2015) 6-Shogaol induces cell cycle arrest and apoptosis in human hepatoma cells through pleiotropic mechanisms. Eur J Pharmacol 762:449–458. https://doi.org/10.1016/j.ejphar.2015.06.032 - PubMed
  24. Ray A, Vasudevan S, Sengupta S (2015) 6-Shogaol inhibits breast cancer cells and stem cell-like spheroids by modulation of notch signaling pathway and induction of autophagic cell death. PLoS One 10(9):e0137614. https://doi.org/10.1371/journal.pone.0137614 - PubMed
  25. Ishiguro K, Ando T, Watanabe O, Goto H (2008) Specific reaction of alpha, beta-unsaturated carbonyl compounds such as 6-shogaol with sulfhydryl groups in tubulin leading to microtubule damage. FEBS Lett 582(23–24):3531–3536. https://doi.org/10.1016/j.febslet.2008.09.027 - PubMed
  26. Gan FF, Nagle AA, Ang X, Ho OH, Tan SH, Yang H, Chui WK, Chew EH (2011) Shogaols at proapoptotic concentrations induce G(2)/M arrest and aberrant mitotic cell death associated with tubulin aggregation. Apoptosis 16(8):856–867. https://doi.org/10.1007/s10495-011-0611-3 - PubMed
  27. Park M, Chae HD, Yun J, Jung M, Kim YS, Kim SH, Han MH, Shin DY (2000) Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest. Cancer Res 60(3):542–545 - PubMed
  28. Xu C, Wang X, Zhu Y, Dong X, Liu C, Zhang H, Liu L, Huang S, Chen L (2016) Rapamycin ameliorates cadmium-induced activation of MAPK pathway and neuronal apoptosis by preventing mitochondrial ROS inactivation of PP2A. Neuropharmacology 105:270–284. https://doi.org/10.1016/j.neuropharm.2016.01.030 - PubMed
  29. Youle RJ, Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9(1):47–59. https://doi.org/10.1038/nrm2308 - PubMed
  30. Gong L, Tang Y, An R, Lin M, Chen L, Du J (2017) RTN1-C mediates cerebral ischemia/reperfusion injury via ER stress and mitochondria-associated apoptosis pathways. Cell Death Dis 8(10):e3080. https://doi.org/10.1038/cddis.2017.465 - PubMed
  31. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G (2007) Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8(9):741–752. https://doi.org/10.1038/nrm2239 - PubMed
  32. Schumacker PT (2006) Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 10(3):175–176. https://doi.org/10.1016/j.ccr.2006.08.015 - PubMed
  33. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44–84. https://doi.org/10.1016/j.biocel.2006.07.001 - PubMed
  34. White E (2012) Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12(6):401–410. https://doi.org/10.1038/nrc3262 - PubMed
  35. Wang G, Zhang T, Sun W, Wang H, Yin F, Wang Z, Zuo D, Sun M, Zhou Z, Lin B, Xu J, Hua Y, Li H, Cai Z (2017) Arsenic sulfide induces apoptosis and autophagy through the activation of ROS/JNK and suppression of Akt/mTOR signaling pathways in osteosarcoma. Free Radic Biol Med 106:24–37. https://doi.org/10.1016/j.freeradbiomed.2017.02.015 - PubMed
  36. Sui X, Chen R, Wang Z, Huang Z, Kong N, Zhang M, Han W, Lou F, Yang J, Zhang Q, Wang X, He C, Pan H (2013) Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis 4:e838. https://doi.org/10.1038/cddis.2013.350 - PubMed
  37. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139(5):871–890. https://doi.org/10.1016/j.cell.2009.11.007 - PubMed
  38. Savagner P (2015) Epithelial-mesenchymal transitions: from cell plasticity to concept elasticity. Curr Top Dev Biol 112:273–300. https://doi.org/10.1016/bs.ctdb.2014.11.021 - PubMed
  39. Javadian M, Gharibi T, Shekari N, Abdollahpour-Alitappeh M, Mohammadi A, Hossieni A, Mohammadi H, Kazemi T (2019) The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis. J Cell Physiol 234(5):5399–5412. https://doi.org/10.1002/jcp.27445 - PubMed
  40. Cheng G, Gao F, Sun X, Bi H, Zhu Y (2016) Paris saponin VII suppresses osteosarcoma cell migration and invasion by inhibiting MMP2/9 production via the p38 MAPK signaling pathway. Mol Med Rep 14(4):3199–3205. https://doi.org/10.3892/mmr.2016.5663 - PubMed
  41. Porta C, Paglino C, Mosca A (2014) Targeting PI3K/Akt/mTOR signaling in cancer. Front Oncol 4:64. https://doi.org/10.3389/fonc.2014.00064 - PubMed
  42. Ciruelos Gil EM (2014) Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer. Cancer Treat Rev 40(7):862–871. https://doi.org/10.1016/j.ctrv.2014.03.004 - PubMed

Substances

MeSH terms

Publication Types